Top results

Psychiatric Scale NPsychlopedia

Psychiatric scales and related tools can be helpful in screening, diagnosing, and monitoring your patients. Learn more about some of the different psychiatric scales here.

Psychiatric rating scales are commonly used in both research and clinical practice to facilitate patient evaluations for mental health. Scales are designed to meet various needs, including screening, diagnosis, and treatment monitoring. Explore our Psychiatric Scales NPsychlopedia for assessment tools you may be able to incorporate into your daily practice.  The decision about which tool to use will vary and should be dictated by the setting you practice in, the age of your patient, and the instrument’s intended use.

This list is provided for educational purposes only. The scales described here are provided for your convenience. This is not an exhaustive list. AbbVie Inc. does not endorse or recommend the use of any specific scale. Healthcare providers should use their clinical judgment when reviewing educational resources on NP Psych Navigator.

Please note: While each category in the drop-down menu has been independently validated, the combinations across categories have not all been examined in the literature. Additional research may be needed in order to confirm whether a particular scale is appropriate for a particular patient population.

Refine this list

Filter

Sort

Antidepressant Treatment Response Questionnaire (ATRQ)

The Massachusetts General Hospital (MGH) Antidepressant Treatment Response Questionnaire (ATRQ) is a scale used to assess treatment response or nonresponse to adequate treatment trials among patients with major depressive disorder (MDD).1 The ATRQ examines the adequacy of duration and dose of prior and current antidepressant treatment trials.2 The ATRQ also assesses the degree of improvement in depressive symptoms in the most efficacious trial or in all trials during the current episode.2 The utility of this scale is in allowing a patient-report tool to take the place of a potentially lengthy clinician interview in assessing past antidepressant treatment adequacy and efficacy.1  

Barnes Akathisia Rating Scale (BARS)

The Barnes Akathisia Rating Scale (BARS) is a brief, 4-item scale used to assess the severity of akathisia in patients taking antipsychotic medications.1

Brief Negative Symptoms Scale (BNSS)

The Brief Negative Symptom Scale (BNSS) was designed to assess negative symptoms of schizophrenia in a way that can be easily implemented into clinical research.1,2

Clinical Global Impression (CGI)

The Clinical Global Impression (CGI) is a 3-item, clinician-rated scale used to assess global illness severity, overall improvement from the start of treatment, and therapeutic response. The scale was designed to be universal and can be administered to a wide variety of patient populations.

Clinically Useful Depression Outcome Scale (CUDOS)

The Clinically Useful Depression Outcome Scale (CUDOS) is a brief, quickly scored, self-report scale used to assess depressive symptoms over the past 1 week. CUDOS is reliable, valid, and sensitive to change.1 The CUDOS consists of 18 questions. The first 16 are scored from 0 to 4 for frequency of symptoms over the past week. The final 2 questions cover the impact of these symptoms on the respondent’s life and their overall quality of life in the past week.2

Columbia Suicide Severity Rating Scale (C-SSRS)

The Columbia Suicide Severity Rating Scale (C-SSRS), also known as the “Columbia Protocol,” is an interview-based tool used to quantify suicidal ideation and suicidal behavior in a patient. The C-SSRS was designed to be usable by anyone in any situation.

DSM-5 Cultural Formulation Interview

The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) Cultural Formulation Interview (CFI) is a structured interview to help clinicians assess the impact of cultural features or other factors that might be relevant to a patient’s diagnosis or treatment.1,2 It was developed by the American Psychiatric Association’s DSM-5 Cross-Cultural Issues Subgroup.1

Epworth Sleepiness Scale (ESS)

The Epworth Sleepiness Scale (ESS) is used to assess daytime sleepiness in adults.1 The prevalence of daytime sleepiness in people with depressive symptoms is high—ranging from about 40% to 50%.2  Clinicians can consider using the ESS to measure daytime sleepiness in patients experiencing depressive episodes. The ESS has demonstrated a positive association with depressive scores (eg, on the Beck Depression Inventory) in people with Major Depressive Disorder (MDD).3

Welcome To NP Psych Navigator

This website is intended for healthcare professionals inside the United States.
Please confirm that you are a healthcare professional inside the US.

No, I am not US Healthcare professional

You are now leaving NP Psych Navigator

Links to sites outside of NP Psych Navigator are provided as a resource to the viewer. AbbVie Inc accepts no responsibility for the content of non-AbbVie linked sites.

Redirect to:

Please to bookmark content